Reata Pharmaceuticals, Inc. - (RETA) Social Stream
Reata Pharmaceuticals Inc (RETA) Price Targets From Analysts
Use the tables below to see what analysts covering Reata Pharmaceuticals Inc think about its future price and what recommendations they have for investors and traders.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
RETA's average price target has moved down $164.62 over the prior 14 months.
Over the past 48 weeks, RETA's average upside potential has been 124.58%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
RETA Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
RETA's average broker recommendation rating worsened by 0.5 over the prior 120 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Reata Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is higher than 543.73% of all US stocks.
- In the context of all US stocks, Reata Pharmaceuticals Inc's variance in analysts' estimates is lower than -434.04% of them.
- RETA has a greater average analyst price target than 534.73% of Pharmaceutical Products stocks.
- In terms of how Reata Pharmaceuticals Inc fares relative to Pharmaceutical Products stocks, note that its number of analysts covering the stock is greater than 396.18% of that group.
In the Pharmaceutical Products industry, RDUS, RCUS, and RCKT are the three stocks most similar to Reata Pharmaceuticals Inc regarding the price target and analyst recommendation information presented here.
What is the outlook for RETA? Use POWR Ratings for clearer insight into price direction.